# Antibody-Drug Conjugates for Ovarian Cancer — An Interview with Dr Kathleen N Moore

Page: https://stenobird.com/podcast/gynecologic-oncology-update-612940/antibody-drug-conjugates-for-ovarian-cancer-an-interview-with-dr-kathleen-n-moore
Text version: https://stenobird.com/podcast/gynecologic-oncology-update-612940/antibody-drug-conjugates-for-ovarian-cancer-an-interview-with-dr-kathleen-n-moore.md
Podcast: [Gynecologic Oncology Update](https://stenobird.com/podcast/gynecologic-oncology-update-612940)
Published: 2026-02-09T18:00:00+00:00
Episode link: https://gynecologic-oncology.captivate.fm/episode/5820-oncologytodayadcsovarian25
Audio file: https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/379d2bce-f4d9-4fe8-91a1-c12d3030594c.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/gynecologic-oncology-update-612940/episodes/antibody-drug-conjugates-for-ovarian-cancer-an-interview-with-dr-kathleen-n-moore
Duration seconds: 3296

## Resource

Dr Kathleen N Moore from the Fred and Pamela Buffett Cancer Center in Omaha, Nebraska, discusses recent updates on available and novel treatment strategies with antibody-drug conjugates for ovarian cancer. CME information and select publications here .

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/gynecologic-oncology-update-612940/episodes/antibody-drug-conjugates-for-ovarian-cancer-an-interview-with-dr-kathleen-n-moore/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/gynecologic-oncology-update-612940/antibody-drug-conjugates-for-ovarian-cancer-an-interview-with-dr-kathleen-n-moore.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.